Inoviq Ltd
INOVIQ Ltd develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. It offers hTERT ICC test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET, an EV isolation tool for biomarker discovery and diagnostic development. It offers non… Read more
Market Cap & Net Worth: Inoviq Ltd (IIQ)
Inoviq Ltd (AU:IIQ) has a market capitalization of $29.20 Million (AU$47.16 Million) as of March 19, 2026. Listed on the AU stock exchange, this Australia-based company holds position #24790 globally and #520 in its home market, demonstrating a 3.08% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Inoviq Ltd's stock price AU$0.34 by its total outstanding shares 140775458 (140.78 Million).
Inoviq Ltd Market Cap History: 2016 to 2026
Inoviq Ltd's market capitalization history from 2016 to 2026. Data shows change from $86.26 Million to $29.20 Million (-7.26% CAGR).
Inoviq Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Inoviq Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
18.61x
Inoviq Ltd's market cap is 18.61 times its annual revenue
0.69x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $17.76 Million | $44.03K | -$2.60 Million | 403.28x | N/A |
| 2018 | $57.05 Million | $62.42K | -$1.82 Million | 914.01x | N/A |
| 2019 | $88.91 Million | $8.73K | -$1.72 Million | 10184.39x | N/A |
| 2020 | $59.27 Million | $98.39K | -$3.25 Million | 602.43x | N/A |
| 2021 | $104.16 Million | $1.27 Million | -$11.15 Million | 81.95x | N/A |
| 2022 | $55.79 Million | $276.75K | -$18.20 Million | 201.58x | N/A |
| 2023 | $57.97 Million | $398.19K | -$8.97 Million | 145.57x | N/A |
| 2024 | $44.89 Million | $535.12K | -$6.55 Million | 83.89x | N/A |
| 2025 | $33.78 Million | $1.82 Million | -$6.93 Million | 18.61x | N/A |
Competitor Companies of IIQ by Market Capitalization
Companies near Inoviq Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Inoviq Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Inoviq Ltd Historical Marketcap From 2016 to 2026
Between 2016 and today, Inoviq Ltd's market cap moved from $86.26 Million to $ 29.20 Million, with a yearly change of -7.26%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$29.20 Million | -13.55% |
| 2025 | AU$33.78 Million | -24.76% |
| 2024 | AU$44.89 Million | -22.56% |
| 2023 | AU$57.97 Million | +3.91% |
| 2022 | AU$55.79 Million | -46.44% |
| 2021 | AU$104.16 Million | +75.74% |
| 2020 | AU$59.27 Million | -33.33% |
| 2019 | AU$88.91 Million | +55.84% |
| 2018 | AU$57.05 Million | +221.31% |
| 2017 | AU$17.76 Million | -79.42% |
| 2016 | AU$86.26 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Inoviq Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $29.20 Million USD |
| MoneyControl | $29.20 Million USD |
| MarketWatch | $29.20 Million USD |
| marketcap.company | $29.20 Million USD |
| Reuters | $29.20 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.